FDA Inspection 1259404 — MD Tox Laboratory

MD Tox Laboratory — FEI 3011213917

The FDA completed an inspection of MD Tox Laboratory on January 28, 2025 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 28, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1231021 CFR 1271.160(a)All core requirements covered in program
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1243721 CFR 1271.270(a)Records incomplete
1243821 CFR 1271.270(b)Management system re: core CGTPs
1244321 CFR 1271.270(d)Retention time (10 year rules)